Drug Profile
Research programme: amyotrophic lateral sclerosis therapeutics - SK biopharmaceuticals
Alternative Names: TDP-43 inhibitors - SK biopharmaceuticalsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator SK biopharmaceuticals
- Class
- Mechanism of Action TDP-43 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Amyotrophic-lateral-sclerosis in South Korea
- 19 Sep 2011 Early research in Amyotrophic lateral sclerosis in South Korea (unspecified route)